New strategy for the design, production and pre-purification of chimeric peptide with immunomodulatory activity in Salmo salar

The intensive salmon farming is associated with massive outbreaks of infections. The use of antibiotics for their prevention and control is related to damage to the environment and human health. Antimicrobial peptides (AMPs) have been proposed as an alternative to the use of antibiotics for their antimicrobial and immunomodulatory activities. However, one of the main challenges for its massive clinical application is the high production cost and the complexity of chemical synthesis. Thus, recombinant DNA technology offers a more sustainable, scalable, and profitable option. In the present study, using an AMPs function prediction methodology, we designed a chimeric peptide consisting of sequences derived from cathelicidin fused with the immunomodulatory peptide derived from flagellin. The designed peptide, CATH-FLA was produced by recombinant expression using an easy pre-purification system. The chimeric peptide was able to induce IL-1 beta and IL-8 expression in Salmo salar head kidney leukocytes, and prevented Piscirickettsia salmonis-induced cytotoxicity in SHK-1 cells. These results suggest that pre-purification of a recombinant AMP-based chimeric peptide designed in silico allow obtaining a peptide with immunomodulatory activity in vitro. This could solve the main obstacle of AMPs for massive clinical applications.

Automated summary

Intensive salmon farming has led to outbreaks of infections, and the use of antibiotics for prevention and control has negative impacts on the environment and human health. Therefore, antimicrobial peptides (AMPs) have been proposed as an alternative. However, the main challenges for their large-scale clinical application are high production costs and complex chemical synthesis. Recombinant DNA technology offers a more sustainable and scalable option, and the designed chimeric peptide demonstrated immunomodulatory activity.